OpenAI is paying employees more than any tech startup in recent history, according to financial data it has shown investors. The company’s stock-based compensation is about $1.5 million per employee, ...

Hilarious spelling mistakes that completely change the meaning. Trump officials restrict top ratings for staff across federal agencies Men’s lazy habit fueling millennial "dating crisis" revealed ...

SACRAMENTO, Calif. (CN) — California’s legislative analyst on Tuesday called newly passed legislation targeting the state’s cap-and-invest program significant in lawmakers’ attempts to reduce ...

BUFFALO, N.Y. — If they don't offer a retirement plan already, businesses in New York State with more than 10 workers will be required to enroll them into a state-sponsored plan called the New York ...

A decline in speculative crypto investor appetite has seen Pump.fun’s revenue fall by 50% since October, raising concerns about incoming selling pressure. Update Nov. 25, 7:00 a.m. UTC: This article ...

A former employee of the Department of Veterans Affairs has been charged in San Diego federal court with running a criminal scheme in which he allegedly coached veterans on how to fraudulently obtain ...

Ribbon Bio GmbH, the DNA synthesis company, has been named A Best Place to Work 2025 by GenomeWeb in the mid-size category of 51-100 employees. This recognition reflects Ribbon’s commitment to ...

Korro Bio, Inc. (NASDAQ: KRRO) stock is sinking on Thursday with a session volume of 6.68 million compared to the average volume of 1.42 million, as per data from Benzinga Pro. The genetic medicines ...

After considerable delay, employer registration for the New York State Secure Choice Savings Program (“New York Secure Choice” or “the Program”) is now open. New York Secure Choice—which was ...

North Carolina Insurance Commissioner Mike Causey talks to reporters Monday, April 24, 2023, at the Albemarle Building in Raleigh, N.C. Starting this month, small businesses in North Carolina will ...

The U.S. FDA’s complete response letter (CRL) for Biohaven Ltd.’s lead asset, troriluzole, to treat spinocerebellar ataxia has prompted a wave of downstream changes at the company. There will be a ...